NXP Semiconductors Aktie

Kaufen
Verkaufen
201,00 EUR -1,00 EUR -0,50 %
207,54 USD +0,27 USD +0,13 %
nachbörslich
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone

Marktkap. 51,55 Mrd. EUR

KGV 21,22 Div. Rendite 1,77%

WKN A1C5WJ

ISIN NL0009538784

Symbol NXPI


NXP Semiconductors Aktie Analyse

02.11.18 NXP Semiconductors Outperform Cowen and Company, LLC
13.09.18 NXP Semiconductors Outperform Cowen and Company, LLC
07.09.18 NXP Semiconductors Outperform Cowen and Company, LLC
27.07.18 NXP Semiconductors Buy Deutsche Bank AG
03.05.18 NXP Semiconductors Buy Drexel Hamilton
01.02.18 NXP Semiconductors Strong Buy Needham & Company, LLC
27.10.16 NXP Semiconductors Buy Mizuho
27.04.16 NXP Semiconductors Buy Topeka Capital Markets
18.11.15 NXP Semiconductors Outperform FBR Capital
30.10.15 NXP Semiconductors Outperform BMO Capital Markets
30.10.15 NXP Semiconductors Buy Canaccord Adams
30.10.15 NXP Semiconductors Outperform Oppenheimer & Co. Inc.
31.07.15 NXP Semiconductors Buy Stifel, Nicolaus & Co., Inc.
29.05.15 NXP Semiconductors Buy Stifel, Nicolaus & Co., Inc.
22.05.15 NXP Semiconductors Buy Mizuho
11.05.15 NXP Semiconductors Buy Deutsche Bank AG
30.04.15 NXP Semiconductors Outperform FBR Capital
27.04.15 NXP Semiconductors Buy Canaccord Adams
13.03.15 NXP Semiconductors Strong Buy Needham & Company, LLC
03.03.15 NXP Semiconductors Buy Topeka Capital Markets
02.03.15 NXP Semiconductors Outperform FBR Capital
06.02.15 NXP Semiconductors Buy Canaccord Adams
05.02.15 NXP Semiconductors Buy Topeka Capital Markets
05.02.15 NXP Semiconductors Outperform FBR Capital
09.12.14 NXP Semiconductors Outperform Oppenheimer & Co. Inc.
04.12.14 NXP Semiconductors Buy Stifel, Nicolaus & Co., Inc.
07.11.14 NXP Semiconductors Buy Topeka Capital Markets
06.11.14 NXP Semiconductors Buy Stifel, Nicolaus & Co., Inc.
05.11.14 NXP Semiconductors Outperform FBR Capital
04.01.12 NXP Semiconductors overweight Barclays Capital